ROYAL BANK OF CANADA - CLEVELAND BIOLABS INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2021$20,000
+5.3%
3,6200.0%0.00%
Q1 2021$19,000
+58.3%
3,6200.0%0.00%
Q4 2020$12,000
+71.4%
3,6200.0%0.00%
Q3 2020$7,000
-68.2%
3,620
-58.0%
0.00%
Q2 2020$22,000
+266.7%
8,620
+138.1%
0.00%
Q1 2020$6,000
+200.0%
3,620
-0.1%
0.00%
Q4 2019$2,000
-50.0%
3,625
+0.0%
0.00%
Q3 2019$4,000
-20.0%
3,624
-0.1%
0.00%
Q2 2019$5,000
-16.7%
3,627
-0.1%
0.00%
Q1 2019$6,000
+50.0%
3,6310.0%0.00%
Q4 2018$4,0003,631
+32909.1%
0.00%
Q3 2018$011
+1000.0%
0.00%
Q4 2017$010.0%0.00%
Q3 2017$0
-100.0%
1
-100.0%
0.00%
Q4 2015$9,0002,6200.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2021
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 1,800$8,0000.01%
VANGUARD GROUP INC 4,644,077$162,991,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 38,888$158,0000.00%
Winfield Associates, Inc. 786$3,0000.00%
Virtu KCG Holdings LLC 11,022$48,0000.00%
UBS Group AG 182$00.00%
BLACKROCK ADVISORS LLC 2,800$12,0000.00%
US BANCORP \DE\ 100$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 37$00.00%
BANK OF AMERICA CORP /DE/ 150$1,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders